Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-19

Maulin Patel, Andrew Gangemi, Robert Marron, Junad Chowdhury, Ibraheem Yousef, Matthew Zheng, Nicole Mills, Lauren Tragesser, Julie Giurintano, Rohit Gupta, Matthew Gordon, Parth Rali, Gilbert D’Alonzo, David Fleece, Huaqing Zhao, Nicole Patlakh, Gerard J. Criner, for the Temple University COVID-19 Research Group
doi: https://doi.org/10.1101/2020.05.22.20109355
Maulin Patel
1Department of Thoracic Medicine and Surgery, Temple University Hospital.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: maulin.patel{at}tuhs.temple.edu
Andrew Gangemi
1Department of Thoracic Medicine and Surgery, Temple University Hospital.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Marron
1Department of Thoracic Medicine and Surgery, Temple University Hospital.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junad Chowdhury
1Department of Thoracic Medicine and Surgery, Temple University Hospital.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ibraheem Yousef
1Department of Thoracic Medicine and Surgery, Temple University Hospital.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Zheng
1Department of Thoracic Medicine and Surgery, Temple University Hospital.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicole Mills
1Department of Thoracic Medicine and Surgery, Temple University Hospital.
DO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauren Tragesser
1Department of Thoracic Medicine and Surgery, Temple University Hospital.
MS4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Giurintano
2Lewis Katz School of Medicine at Temple University.
MS4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rohit Gupta
1Department of Thoracic Medicine and Surgery, Temple University Hospital.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Gordon
1Department of Thoracic Medicine and Surgery, Temple University Hospital.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Parth Rali
1Department of Thoracic Medicine and Surgery, Temple University Hospital.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilbert D’Alonzo
1Department of Thoracic Medicine and Surgery, Temple University Hospital.
DO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Fleece
1Department of Thoracic Medicine and Surgery, Temple University Hospital.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huaqing Zhao
2Lewis Katz School of Medicine at Temple University.
Phd
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicole Patlakh
2Lewis Katz School of Medicine at Temple University.
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerard J. Criner
1Department of Thoracic Medicine and Surgery, Temple University Hospital.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Invasive mechanical has been associated with high mortality in COVID-19. Alternative therapy of High flow nasal therapy (HFNT) has been greatly debated around the world for use in COVID-19 pandemic due to concern for increased healthcare worker transmission.

Methods This was a retrospective analysis of consecutive patients admitted to Temple University Hospital in Philadelphia, Pennsylvania, from March 10, 2020, to April 24, 2020 with moderate to severe respiratory failure treated with High Flow nasal therapy (HFNT). Primary outcome was prevention of intubation.

Results Of the 445 patients with COVID-19, 104 met our inclusion criteria. The average age was 60.66 (±13.50) years, 49 (47.12 %) were female, 53 (50.96%) were African American, 23 (22.12%) Hispanic. Forty-three patients (43.43%) were smokers. SF and chest Xray scores had a statistically significant improvement from day 1 to day 7. 67 of 104 (64.42%) were able to avoid invasive mechanical ventilation in our cohort. Incidence of hospital/ventilator associated pneumonia was 2.9%. Overall, mortality was 14.44% (n=15) in our cohort with 13 (34.4%) in the progressed to intubation group and 2 (2.9%) in the non-intubation group. Mortality and incidence of VAP/HAP was statistically higher in the progressed to intubation group.

Conclusion HFNT use is associated with a reduction in the rate of Invasive mechanical ventilation and overall mortality in patients with COVID-19 infection.

Key Question What is the utility of High Flow Nasal Therapy (HFNT) in COVID-19 related Hypoxemic Respiratory Failure?

Bottom Line In this retrospective analysis of moderate to severe hypoxic respiratory failure for COVID 19 patients, 67 patients (65.4%) were able to avoid intubation despite severely low SF ratio (Mean 121.9).

Why Read on HFNT has a significant role in COVID-19 for reducing rate of intubations and associated mortality

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding was received for this study

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Temple University Institutional Review Board (TU IRB protocol: 27051

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* -see supplement

  • None of the authors have any conflict of interest related to the material discussed in this article

Data Availability

All data will be available upon request. All requests can be made to the corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 26, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-19
Maulin Patel, Andrew Gangemi, Robert Marron, Junad Chowdhury, Ibraheem Yousef, Matthew Zheng, Nicole Mills, Lauren Tragesser, Julie Giurintano, Rohit Gupta, Matthew Gordon, Parth Rali, Gilbert D’Alonzo, David Fleece, Huaqing Zhao, Nicole Patlakh, Gerard J. Criner, for the Temple University COVID-19 Research Group
medRxiv 2020.05.22.20109355; doi: https://doi.org/10.1101/2020.05.22.20109355
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-19
Maulin Patel, Andrew Gangemi, Robert Marron, Junad Chowdhury, Ibraheem Yousef, Matthew Zheng, Nicole Mills, Lauren Tragesser, Julie Giurintano, Rohit Gupta, Matthew Gordon, Parth Rali, Gilbert D’Alonzo, David Fleece, Huaqing Zhao, Nicole Patlakh, Gerard J. Criner, for the Temple University COVID-19 Research Group
medRxiv 2020.05.22.20109355; doi: https://doi.org/10.1101/2020.05.22.20109355

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Respiratory Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)